Synthesis and antitumor activities of NO-donating rhein derivatives
10.11665/j.issn.1000-5048.20210105
- VernacularTitle:NO供体型大黄酸衍生物的合成及抗肿瘤活性
- Author:
Zhiwei BAI
1
;
Feiyang SHANG
;
Weiguo DAI
;
Liqin HE
Author Information
1. 安徽中医药大学药学院
- Publication Type:Journal Article
- Keywords:
rhein;
derivatives;
furoxan;
synthesis;
anti-tumor activity
- From:
Journal of China Pharmaceutical University
2021;52(1):38-43
- CountryChina
- Language:Chinese
-
Abstract:
Seven target compounds coupled by rhein and furoxan were synthesized and their chemical structures were confirmed by 1H NMR, IR, and MS. All target compounds were evaluated for anti-proliferative activity against human hepatoma cells HepG2 and Bel-7402, human colon cancer cells HCT116, human osteosarcoma cells U2OS, drug-resistant cells Bel-7402/5-FU and normal hepatocytes cells LO2 in vitro by thiazolyl blue(MTT) colorimetry. The results indicated that all target compounds had more potent anti-proliferative activity than their parent compound rhein. Additionally, compound 4g had stronger proliferation inhibitory activity on HepG2, Bel-7402, U2OS and Bel-7402/5-FU,with little effect on the proliferation of normal cells, exhibiting selective inhibitory activity. Griess assay was used to measure the release of nitric oxide in vitro. Results showed that compound 4g could increase the releases NO in HepG2 cells, which may be associated with its antitumor effects. Furthermore, the antitumor activity of compound 4g was attenuated by NO scavenger (hemoglobin), which indicates that the antitumor activity of compound 4g may be partly related to the release of NO.
